Copyright
©The Author(s) 2020.
World J Hepatol. Sep 27, 2020; 12(9): 619-627
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.619
Published online Sep 27, 2020. doi: 10.4254/wjh.v12.i9.619
Co-morbid condition | cCCI weights | uCCI weights |
Myocardial infarction | 1 | 0 |
Congestive heart failure | 1 | 2 |
Peripheral vascular disease | 1 | 0 |
Cerebrovascular disease | 1 | 0 |
Dementia | 1 | 2 |
Chronic obstructive pulmonary disease | 1 | 1 |
Connective tissue disorder | 1 | 1 |
Peptic ulcer disease | 1 | 0 |
Mild liver disease | 1 | 2 |
Diabetes without complication | 1 | 0 |
Diabetes with complication | 2 | 1 |
Hemiplegia or paraplegia | 2 | 2 |
Chronic kidney disease stage III | 2 | 1 |
Any malignancy without metastasis | 2 | 2 |
Leukemia | 2 | |
Lymphoma | 2 | |
Moderate or severe liver disease | 3 | 4 |
Metastatic tumor | 6 | 6 |
AIDS | 6 | 4 |
Maximum score | 33 | 24 |
- Citation: Suresh Kumar VC, Harne PS, Mukherjee S, Gupta K, Masood U, Sharma AV, Lamichhane J, Dhamoon AS, Sapkota B. Transaminitis is an indicator of mortality in patients with COVID-19: A retrospective cohort study. World J Hepatol 2020; 12(9): 619-627
- URL: https://www.wjgnet.com/1948-5182/full/v12/i9/619.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i9.619